SCHOTT PHARMA AG & CO. KGAA |
Market Closed -
Other stock markets
|
After market 01:18:30 pm | |||
| 36.66 EUR | -0.97% |
|
36.69 | +0.08% |
| 08:54am | SCHOTT PHARMA : Gets a Neutral rating from Barclays | ZD |
| Apr. 22 | SCHOTT PHARMA : Jefferies remains Neutral | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.
Calendar
2024-06-26
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
37.02
EUR
Average target price
38.67
EUR
Spread / Average Target
+4.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.11% | 6.01B | |
| -4.73% | 182B | |
| +0.22% | 110B | |
| -3.77% | 67.92B | |
| +2.70% | 50.96B | |
| +9.51% | 44.7B | |
| +2.70% | 40.66B | |
| +21.85% | 27.6B | |
| +3.93% | 26.63B | |
| -0.33% | 24.98B |
- Stock Market
- Equities
- 1SXP Stock
- News SCHOTT Pharma AG & Co. KGaA
- Schott Pharma Plans New Syringe Manufacturing Facility in US
